Palisade Bio Stock (NASDAQ: PALI) stock price, news, charts, stock research, profile.
Open | $6.100 |
Close | $6.230 |
Volume / Avg. | 71.811K / 1.048M |
Day Range | 5.720 - 6.400 |
52 Wk Range | 3.820 - 36.600 |
Market Cap | $5.253M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 3.77% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Palisade Bio (NASDAQ: PALI) through any online brokerage.
Other companies in Palisade Bio’s space includes: Cingulate (NASDAQ:CING), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Hepion Pharmaceuticals (NASDAQ:HEPA) and Cadrenal Therapeutics (NASDAQ:CVKD).
The latest price target for Palisade Bio (NASDAQ: PALI) was reported by Maxim Group on Tuesday, April 16, 2024. The analyst firm set a price target for 22.50 expecting PALI to rise to within 12 months (a possible 264.67% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Palisade Bio (NASDAQ: PALI) is $6.17 last updated Today at April 25, 2024 at 5:03 PM EDT.
There are no upcoming dividends for Palisade Bio.
Palisade Bio’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Palisade Bio.
Palisade Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.